How Gambit Bio Intends to Redefine Cancer Diagnostics
According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for the loss of 10 million lives in 2020. To prevent these deaths, cancer needs to be detected at an early stage. But detection remains a challenge, particularly in lower-income countries, where there is a dearth of diagnostic tools.
How Gambit Bio Intends to Redefine Cancer Diagnostics Read More »
According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for the loss of 10 million lives in 2020. To prevent these deaths, cancer needs to be detected at an early stage. But detection remains a challenge, particularly in lower-income countries, where there is a dearth of diagnostic tools.














